ClosedNo longer accepting applications
RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
This opportunity closed July 30, 2026. 5 similar opportunities are open right now.
Similar opportunities open now
- DEVELOPMENT OF A FORMULATION-AGNOSTIC AUTOINJECTOR PLATFORMOpenDEPT OF DEFENSENo deadline listed
- JPEO-CBRND CWMD BOTAA-24-01OpenDEPT OF DEFENSECloses Feb 2029
- BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EBOpenDEPT OF DEFENSECloses Jun 2027
- Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partnersOpenDEPT OF DEFENSECloses Oct 2028
- Generally Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partnersOpenDEPT OF DEFENSECloses Oct 2028
About this archived opportunity
BARDA seeks late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program.
Historical details
- Status
- Closed
- Deadline
- July 30, 2026
- First captured
- July 3, 2026
- Publisher reference
- 475c5939d56548529d8a1d73665697e7
Eligibility: No Set aside used. NONE
Free. One email, sent if this program reopens or a close match to it opens. We watch for 12 months, then stop. No list.
Related opportunities
- DEVELOPMENT OF A FORMULATION-AGNOSTIC AUTOINJECTOR PLATFORMDEPT OF DEFENSE
- DEVELOPMENT OF A FORMULATION-AGNOSTIC AUTOINJECTOR PLATFORMDEPT OF DEFENSE
- DEVELOPMENT OF A FORMULATION-AGNOSTIC AUTOINJECTOR PLATFORMDEPT OF DEFENSE
- JPEO-CBRND CWMD BOTAA-24-01DEPT OF DEFENSECloses Feb 2029
- BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EBDEPT OF DEFENSECloses Jun 2027
- Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partnersDEPT OF DEFENSECloses Oct 2028